Multibagger Selection: Muse Spark 1.1's picks
Muse Spark 1.1 picked ORIC, VSTM, LAC, SG, ENVX with a twelve-month thesis, measured against SPY at each checkpoint.
| Experiment | Multibagger Selection |
|---|---|
| Model | Muse Spark 1.1 |
| Prompt version | multibagger-selection-v1 |
| Asked | |
| Horizon | 12-month |
| Benchmark | SPY |
| Status | Being measured |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | ORIC | — | 68% | — | — |
| 2 | VSTM | — | 62% | — | — |
| 3 | LAC | — | 60% | — | — |
| 4 | SG | — | 58% | — | — |
| 5 | ENVX | — | 55% | — | — |
Checkpoints
| Checkpoint | Portfolio return | Return vs SPY | Best peak multiple | Picks reaching 2x |
|---|---|---|---|---|
| 1 week | +1.83% | +2.73% | 1.18x | 0 |
The model's market view
Small-cap multibagger setup favors companies with verified cash runway into 2028 and a specific near-term catalyst. Biotech Phase 3 readouts and commercial ramps (ORIC, VSTM), lithium project financing at Thacker Pass (LAC), fast-casual unit expansion to profitability (SG), and battery cell qualification (ENVX) all provide time-bound catalysts. Market caps $0.55B-$1.3B leave room for 3x if execution hits, while average dollar volume >$5M ensures tradability.
Why each pick
ORIC
Clinical-stage oncology with two small molecules ORIC-533 and ORIC-944 targeting resistance mechanisms. Stock up 8.5% Oct 15 after 【entity-JPMorgan¦canonical_name=JPMorgan】 raised target $23 to $26 with Overweight rating. Strong cash balance provides runway.
VSTM
Verastem Oncology developing avutometinib for ovarian cancer. RAMP 201 data positive, stock trading $9.50 Oct 15 with market cap $698.25M as of Oct 14 2026, up 20.08% YoY. Recent $234M financing transaction Oct 14 2026 with Jefferies/Guggenheim for 30.9M shares provides cash for commercial launch.
LAC
Lithium Americas owns Thacker Pass, one of largest US lithium deposits, designed to produce battery-grade lithium carbonate for EV. Stock rose 8.9% Oct 15 after Canaccord upgrade from Hold to Speculative Buy, trading $2.2550 vs prior close $2.07, volume 6M shares vs avg 10.9M. Market cap $821.2M.
SG
【entity-Sweetgreen¦canonical_name=Sweetgreen】 fast-casual salad chain, $682M revenue from company-owned US restaurants, founder-led. Stock set new 52-week high after analyst upgrade Oct 15, trading $10.10 with market cap $1.20B and volume 3.77M shares, up 27.57% one month. Path from loss to profitability via digital ordering and unit economics.
ENVX
Enovix develops silicon-anode lithium-ion batteries, market cap $550.82M, price $2.68 Oct 15 2026, down 77% in one year creating washed-out valuation. Battery qualification with leading smartphone OEM provides inflection. Revenue ramp potential large if qualified.
Other models on the same run
| Model | Picks |
|---|---|
| Gemini 3 Pro | RCAT, EOSE, SOUN, MGNI, SERV |
| Perplexity | MAZE, ETON, AAPG, TPC, GPOR |
| Grok 4 | INOD, ONDS, LUNR, DAVE, FEIM |
| DeepSeek | LQDA, ESTA, INOD, CBLL, MLTX |
| GPT-6 | AMPX, PRCH, ADTN, OUST, EOSE |
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.